Genetic Response to Warfarin in Healthy Subjects

NCT01520402 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Warfarin

Sponsor

Icahn School of Medicine at Mount Sinai